Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Genetic testing beneficial as a diagnostic tool for adults with epilepsy
ORLANDO — Genetic testing, which is likely to identify underlying genetic causes for the condition, should be a component of diagnostic evaluations for adult patients with epilepsy, according to new research.
Multiple factors affect access to surgical care for youths with drug-resistant epilepsy
ORLANDO — For U.S. pediatric patients with drug-resistant epilepsy, disparities in surgical care exist with respect to age, socioeconomic and insurance variables, leading to differences in long-term outcomes, according to research.
Log in or Sign up for Free to view tailored content for your specialty!
Seizures associated with earlier decline to MCI in cognitively healthy adults
ORLANDO — In cognitively healthy adults, the presence of seizures predicted earlier change from normal cognition to mild cognitive impairment but was not associated with change from MCI to dementia. according to research.
Triptans, ergots, anti-emetics most effective acute migraine treatments
Among seven classes and 25 individual medications, triptans, ergots and anti-emetics were the most effective acute treatments for individuals with migraine, according to research published in Neurology.
'A Promethean moment': Psychedelics could be prescribed in the next few years
With potential FDA approvals on the horizon, the controversy surrounding psychedelics in clinical practice may soon reach a tipping point, according to experts.
What you need to know if you inherit an individual retirement account
As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.
Rett syndrome gene therapy trial expanded to include patients aged 12 years and older
Health Canada has authorized an amendment to the ongoing REVEAL phase 1/2 trial evaluating an AAV9 investigational gene transfer therapy that expands eligibility to patients with Rett syndrome aged 12 years and older.
Phase 2 study of Alzheimer’s disease psychosis therapy initiated
A phase 2 clinical trial has been initiated to evaluate the safety and efficacy of an inverse agonist for hallucinations and delusions associated with Alzheimer’s disease psychosis, according to the manufacturer.
FDA clears platform for non-invasive brain chemistry measurement
The FDA has cleared the use of a magnetic resonance spectroscopy platform to provide non-invasive measurement of brain chemistry and support diagnostic processes for a range of brain-related illnesses.
Early-onset heart disease drives risk for Alzheimer's disease, other dementias
Adults with a diagnosis of coronary heart disease before age 45 years are 36% more likely to develop dementia over 13 years of follow-up compared with those without a CHD diagnosis, data from the UK Biobank show.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read